Management ChangeAug 3, 2026, 09:38 AM
Silexion Appoints Avner Lushi to Audit Committee
AI Summary
Silexion Therapeutics Corp announced that Professor Amnon Peled resigned from its Board of Directors and all committees, including the audit committee, effective August 1, 2026, for personal reasons. Immediately following his resignation, the Board appointed Mr. Avner Lushi, an existing independent board member, to the audit committee. This appointment ensures the Company's audit committee remains in full compliance with Nasdaq listing requirements, consisting of three independent members.
Key Highlights
- Professor Amnon Peled resigned from Silexion's Board and audit committee, effective August 1, 2026.
- His resignation was for personal reasons and not due to any disagreement with the Company.
- Mr. Avner Lushi was appointed to the audit committee, effective August 1, 2026.
- Mr. Lushi has been an independent member of the Board since August 2024.
- The appointment ensures Silexion's audit committee complies with Nasdaq Listing Rule 5605(c)(2)(A).
- The audit committee now comprises Dror J. Abramov (Chair), Ruth Alon, and Avner Lushi.
Price Impact
More from SLXN